Pricing
  1. US-listed companies
  2. IDEXX LABORATORIES INC
  3. Financials
  4. Repurchases of common stock

IDEXX LABORATORIES INC (IDXX)

Market cap
$45.8B
P/E ratio
SummaryFinancials
Period EndRepurchases of common stock (Million USD)YoY (%)
Dec 31, 2024837+1063.84%
Dec 31, 202372-91.23%
Dec 31, 2022820+9.77%
Dec 31, 2021747+308.49%
Dec 31, 2020183-39.40%
Dec 31, 2019302-18.32%
Dec 31, 2018369+30.70%
Dec 31, 2017283-7.08%
Dec 31, 2016304-24.35%
Dec 31, 2015402-34.97%
Dec 31, 2014618+68.09%
Dec 31, 2013368+178.04%
Dec 31, 2012132-48.23%
Dec 31, 2011256+78.56%
Dec 31, 2010143

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat